Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.

The findings, published today in The Lancet, establish pembrolizumab as a new option for patients with this disease. “Soft ...

Plus, my colleagues and Golf Digest instruction nerds, Luke Kerr-Dineen and Drew Powell, both follow Clapp on Instagram. So he must be legit! Thus, using the transitive property, the Sure-Set training ...